Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

28 August 2021: Articles  USA

Viscerocutaneous Loxoscelism Manifesting with Myocarditis: A Case Report

Challenging differential diagnosis, Rare coexistence of disease or pathology

Travis R. Langner A , Hammad A. Ganatra D* , Julianne Schwerdtfager B , William Stoecker B , Stephen Thornton A

DOI: 10.12659/AJCR.932378

Am J Case Rep 2021; 22:e932378



BACKGROUND: Envenomation from the brown recluse spider (Loxosceles reclusa) is described to cause both local and systemic symptoms. We report a case of an adolescent boy who developed severe systemic loxoscelism, and his clinical course was complicated by myocarditis, which has not been previously reported in association with loxoscelism.

CASE REPORT: A 16-year-old boy presented with non-specific symptoms and forearm pain following a suspected spider bite, which subsequently evolved into a necrotic skin lesion. During his clinical course, he developed a characteristic syndrome of systemic loxoscelism with hemolysis, disseminated intravascular coagulopathy, and severe systemic inflammatory response syndrome, necessitating transfer to the Intensive Care Unit. The diagnosis was confirmed with an enzyme-linked immunosorbent assay that detected Loxosceles venom in the wound. Additionally, he developed pulmonary edema and cardiogenic shock secondary to myocarditis, which was confirmed with cardiac magnetic resonance imaging. Steroids and plasmapheresis were initiated to manage the severe inflammatory syndrome, and the myocarditis was treated with intravenous immunoglobulins, resulting in resolution of symptoms and improvement of cardiac function.

CONCLUSIONS: This is the first reported case of myocarditis associated with loxoscelism, providing evidence for Loxosceles toxin-associated cardiac injury, which has been previously described in animal models only. Furthermore, this case provides further support for the use of confirmatory testing in the clinical diagnosis of loxoscelism.

Keywords: Brown Recluse Spider, Loxosceles Venom, myocarditis, Plasmapheresis, Adolescent, Animals, Hemolysis, Humans, Male, Skin Diseases, Spider Bites


Brown recluse spiders (Loxosceles reclusa) are distributed across the central and south-central United States [1,2]. Envenomation by the brown recluse, termed loxoscelism, remains the most common cause of spider envenomation in the country [3] and causes local and systemic complications [4]. Presentation of loxoscelism can vary greatly, and the lack of widely available diagnostic testing poses significant diagnostic challenges. The majority of cases exhibit localized erythema, burning pain, and pruritus, with some cases progressing to necrosis at the bite site. However, systemic or viscerocutaneous loxoscelism can present with fevers and arthralgias and lead to serious complications, including disseminated intravascular coagulopathy (DIC), hemolytic and aplastic anemia, respiratory distress, thrombocytopenia, rhabdomyolysis, and acute kidney injury [4,5]. Viscerocutaneous loxoscelism occurs more frequently in children but remains rare, accounting for 0.7% to 1.8% of cases in the United States [3,5]. The systemic complications of loxoscelism are from a combination of direct, toxin-mediated effects and widespread effects from an activated immune response [5], frequently requiring management in the intensive care setting. Here, we summarize a case of severe viscerocutaneous loxoscelism in a teenage patient, confirmed by an investigational laboratory test and resulting in a systemic immune response, including DIC and severe hemolysis. Additionally, he developed myocarditis during the course of his illness, a previously unreported finding in systemic loxoscelism.

Case Report

A previously healthy 16-year-old male resident of western Missouri presented to the Emergency Department with sore throat, fatigue, myalgias, fever, and left forearm soreness for 1 day. Initial vital signs revealed a temperature of 39.1°C, heart rate of 143 beats per min, and normal respiratory rate, pulse oximetry, and blood pressure. The physical examination revealed a fatigued-appearing teenager with dry mucus membranes and mild cervical lymphadenopathy. A throat examination showed mild erythema of the posterior pharyngeal wall but without exudate. Auscultation revealed a normal lung examination and normal cardiac examination with tachycardia. Mild tenderness was appreciated on his left forearm, which otherwise appeared unremarkable and demonstrated full range of motion. Initial laboratory tests were unremarkable, aside from an elevated creatinine level (Table 1).

Blood cultures were obtained, and he was started on vancomycin and ceftriaxone empirically and admitted for possible sepsis. On hospital day 2, the patient’s forearm soreness evolved into a swollen, tender, and erythematous area, and he recalled sleeping in a basement where spiders were noted. He developed worsening hypotension (blood pressure decreased from 109/53 to 82/39 mmHg over a 12-h period) with persistent tachycardia (heart rate, 130–145 beats per min) and was unresponsive to a fluid challenge, requiring transfer to the pediatric Intensive Care Unit for management of decompen-sated shock. Ionotropic support was initiated, and intra-arterial access was obtained for continuous blood pressure monitoring. Repeat laboratory examination showed transaminitis, with increased bilirubin and C-reactive protein, leukocytosis, and coagulation profile consistent with DIC (Table 1). Owing to worsening hypotension and a concern for a spider bite, the differential diagnosis at this point was septic shock vs loxoscelism.

The medical toxicology department was consulted and agreed with the diagnosis of loxoscelism. Over hospital days 3 to 5, the patient’s left arm became increasingly tender, developing vesicular areas over a darkening, necrotic-appearing base (Figure 1). A skin swab from the lesion was submitted for an enzyme-linked immunosorbent assay (ELISA) to detect Loxosceles venom and was positive (SpiderTek, S&A Tech, Rolla MO). During this time, he also became dyspneic, prompting a chest X-ray that revealed mild pulmonary edema and an echocardiogram that showed acceptable function with an ejection fraction of 55%.

His clinical status acutely worsened on day 6, with hemoglobin dropping precipitously from 12.6 gm/dL to 7.9 gm/dL, and a concomitant increase in LDH, bilirubin, and plasma free hemoglobin suggested intravascular hemolysis. The patient was transfused with packed red blood cells, and methylpredniso-lone was initiated in an attempt to slow hemolysis. He also developed tachycardia with diffuse T-wave changes on electrocardiogram (EKG), which were concerning for myocarditis. B-type natriuretic peptide, troponin-I, and creatine kinase-muscle/brain levels were elevated to 1309 pg/mL, 0.29 ng/mL, and 7.6 ng/mL, respectively, and cardiac magnetic resonance imaging (MRI) demonstrated myocarditis involving the left ventricular apex and the basal portion of the heart, with an ejection fraction of 45% (Figure 2). Myocarditis therapy was initiated with intravenous immunoglobulins and bumetanide was administered to reduce pulmonary edema and volume overload. He demonstrated a favorable clinical response to therapy, along with steadily decreasing troponin-I and B-type natriuretic peptide, normalization of EKG (Figure 3), and improved cardiac function on repeat echocardiogram performed a week later.

Despite ongoing steroidal treatment, the patient’s hemoglobin reached a nadir of 5.9 gm/dL, requiring further transfusions on hospital days 7 and 8. Plasmapheresis was then performed on days 8, 9, 10, and 13. His hematological laboratory results normalized thereafter, and remained stable for the remainder of his hospitalization. His laboratory values continued improving over the subsequent week, and he was discharged home on day 20. His wound responded to standard outpatient wound care (Figure 4), and a follow-up outpatient echocardiogram was normal.


We present a case of severe viscerocutaneous loxoscelism in an adolescent patient with characteristic hemolysis, DIC, and severe systemic inflammatory response as well as previously unreported myocarditis. Diagnosis of loxoscelism envenomation typically depends on clinical presentation, with emphasis on history and physical examination [3,5,6]. Although not commercially available, the ELISA developed at the University of Missouri and used in this case has been previously detailed in the medical literature [7,8]. It is performed on skin swabs obtained from a suspected Loxosceles bite site, and has been proven to be highly specific for Loxosceles venom [9].

The mechanism for development of viscerocutaneous loxoscelism is not fully understood but is suspected to involve multiple molecular and cellular pathways [6,10,11]. The venom itself contains sphingomyelinase-D and alkaline phosphatase and is capable of creating an immune response through complement, neutrophil, and platelet activation as well as by activating collagenase, proteases, esterase, ribonuclease, and deoxyribonuclease [3,6,11]. The toxin causes direct hemolysis via activation of metalloproteinases that cleave glycophorins from red blood cell surfaces to make them targets for complement lysis [6]. Loxosceles venom induces a direct increase in the production of pro-inflammatory cytokines and reduction of anticoagulation factors, leading to a hypercoagulable state and development of DIC [6,12]. The venom also directly damages endothelial cells, leading to blood vessel wall damage that stimulates thrombus formation [6,11,12]. Other studies have shown direct, immune-mediated mechanisms for thrombocytopenia and hemolysis in Loxosceles envenomation [4,10,13]. Additionally, numerous studies have found direct antiglobulin test-positive hemolysis 7 to 10 days into the course of Loxosceles envenomation, establishing an immune-mediated cause of hemolysis [4,10,14,15].

Myocarditis is defined as inflammation of the myocardium, with a wide spectrum of clinical presentation that can range from subclinical disease to fulminant circulatory failure and death [16]. Moreover, survivors of mild to moderate disease can progress to significant morbidity with dilated cardiomyopathy [17]. The clinical picture of myocarditis can be characterized by cardiovascular dysfunction, shock, tachycardia, chest pain, arrhythmias, and pulmonary edema and is supported by laboratory markers of myocardial injury (elevated troponin and creatine kinase-muscle/brain levels) and concurrent inflammation (elevated C-reactive protein and erythrocyte sedimentation rate) [16,18]. Endomyocardial biopsy has historically been the diagnostic criterion standard for myocarditis, but its relatively poor sensitivity and invasive nature and the concurrent risks of anesthesia have made it controversial in current clinical practice. Cardiovascular MRI is now regarded as the noninvasive criterion standard for diagnosing myocarditis [16], allowing noninvasive visualization of myocardial inflammation and ventricular function [17,18]. Our patient’s diagnosis and cardiac function was also confirmed with cardiovascular MRI, and therapy was initiated with intravenous immunoglobulins. Follow-up MRI was not deemed necessary at the time owing to marked clinical improvement following therapy, and is generally not recommended [16]. However, improved cardiac function was demonstrated on follow-up echocardiograph.

Although Loxosceles toxin has been shown to affect the liver and kidney in previous human studies, there are no reports of direct myocardial tissue involvement in any human case of loxoscelism. One previous study showed cardiac complications, whereby congestive heart failure and pleural effusion were attributed to loxoscelism-induced activation of systemic lupus erythematosus [19], rather than to the direct cytotoxic effect of the Loxosceles venom on the myocardium. Animal studies have isolated Loxosceles toxin to murine myocardium, with altered calcium ion transit in cardiomyocytes, indicating loxoscelism-induced myocardial damage [20]. With the exaggerated systemic inflammatory response in cases of viscerocutaneous loxoscelism, it is possible that myocardial injury may be an immune-mediated and toxin-mediated pathophysiology. Research in myocarditis has demonstrated a role for both toxin-mediated and non-specific immune-mediated mechanisms [21,22]. An experimental autoimmune myocarditis model has been utilized in rodents, whereby exposure to extrinsic cardiac myosin sensitizes T cells, which then home to the myocardium and induce an autoimmune reaction against the cardiomyocytes and recruit non-specific inflammatory modulators [21]. Similarly, it is plausible that Loxosceles toxin localizing to cardiomyocytes would be targeted by CD4 T cells, initiating a cascade of non-specific myocardial inflammation, in addition to mediating direct cytotoxic injury to the cardiomyocytes.


In summary, this case highlights previously described features of viscerocutaneous loxoscelism, such as severe inflammatory response, hemolysis, and DIC. To the best of our knowledge, this is also the first reported case of myocarditis associated with loxoscelism, providing new evidence for Loxosceles-toxin associated cardiac injury that has been previously described in mouse models only. ELISA testing for Loxosceles venom detection from the wound site was also utilized and further supports the use of confirmatory testing in the clinical diagnosis of loxoscelism.


1.. Gertsch WJ, Ennik F: Bulletin of the AMNH, 1983; 175 article 3

2.. Vetter RS: J Med Entomol, 2005; 42(4); 512-21

3.. Hogan CJ, Barbaro KC, Winkel K: Ann Emerg Med, 2004; 44(6); 608-24

4.. Elbahlawan LM, Stidham GL, Bugnitz MC: Pediatr Emerg Care, 2005; 21(3); 177-80

5.. Hubbard JJ, James LP: Clin Pediatr (Phila), 2011; 50(3); 252-58

6.. de Souza AL, Malaque CM, Sztajnbok J: Toxicon, 2008; 51(1); 151-56

7.. Stoecker WV, Green JA, Gomez HF: J Am Acad Dermatol, 2006; 55(5); 888-90

8.. Stoecker WV, Wasserman GS, Calcara DA: Mo Med, 2009; 106(6); 425-27

9.. Gomez HF, Krywko DM, Stoecker WV: Ann Emerg Med, 2002; 39(5); 469-74

10.. Levin C, Bonstein L, Lauterbach R: Pediatr Blood Cancer, 2014; 61(8); 1466-68

11.. Swanson DL, Vetter RS: Clin Dermatol, 2006; 24(3); 213-21

12.. Zanetti VC, da Silveira RB, Dreyfuss JL: Blood Coagul Fibrinolysis, 2002; 13(2); 135-48

13.. Lane L, McCoppin HH, Dyer J: Pediatr Dermatol, 2011; 28(6); 685-88

14.. Abraham M, Tilzer L, Hoehn KS, Thornton SL: J Med Toxicol, 2015; 11(3); 364-67

15.. Said A, Hmiel P, Goldsmith M, Dietzen D, Hartman ME: Pediatrics, 2014; 134(5); e1464-67

16.. Dasgupta S, Iannucci G, Mao C: Congenit Heart Dis, 2019; 14(5); 868-77

17.. Martins DS, Ait-Ali L, Khraiche D: Int J Cardiol, 2021; 329; 226-33

18.. Guglin M, Nallamshetty L: Curr Treat Options Cardiovasc Med, 2012; 14(6); 637-51

19.. Martin Nares E, Lopez Iniguez A, Ontiveros Mercado H: Joint Bone Spine, 2016; 83(1); 85-87

20.. Dias-Lopes C, Felicori L, Guimaraes G: Toxicon, 2010; 56(8); 1426-35

21.. Ayach B, Fuse K, Martino T, Liu P: Curr Opin Cardiol, 2003; 18(3); 175-81

22.. Chaudhuri A, Dooris M, Woods ML: J Med Microbiol, 2013; 62(Pt 1); 169-72


19 May 2022 : Case report  Serbia

Bilateral Emphysematous Pyelonephritis Associated with COVID Pneumonia: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.936370  

17 May 2022 : Case report  USA

High-Frequency Oscillatory Ventilation for Refractory Hypoxemia in Severe COVID-19 Pneumonia: A Small Case ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936651  

13 May 2022 : Case report  Japan

A case of exacerbation of haloperidol-induced rhabdomyolysis following the onset of COVID-19

Am J Case Rep In Press; DOI: 10.12659/AJCR.936589  

13 May 2022 : Case report  USA

Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination

Am J Case Rep In Press; DOI: 10.12659/AJCR.936574  

In Press

20 May 2022 : Case report  Canada

Diagnostic Puzzle of Acute Ischemic Stroke Mimics – Seizure Versus Post-Stroke Recrudescence: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.936826  

19 May 2022 : Case report  Saudi Arabia

Extremes of Anemia: The Lowest Hemoglobin Values Probably Ever Reported in the Pediatric Literature Attribu...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936252  

19 May 2022 : Case report  Brazil

Acute Hepatitis with Positive Autoantibodies: A Case of Natalizumab-Induced Early-Onset Liver Injury

Am J Case Rep In Press; DOI: 10.12659/AJCR.936318  

19 May 2022 : Case report  Japan

Successful Percutaneous Fogarty Thrombectomy for Subacute Lower Limb Ischemia Due to Resistant Thrombus in ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936377  

Most Viewed Current Articles

31 Dec 1969 : Case report  USA

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

31 Dec 1969 : Case report  Oman

Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of P...

DOI :10.12659/AJCR.934399

Am J Case Rep 2022; 23:e934399

31 Dec 1969 : Case report  Brazil

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

31 Dec 1969 : Case report  USA

A Rare Case of Coronavirus Disease 2019 Vaccine-Associated Cerebral Venous Sinus Thrombosis Treated with Me...

DOI :10.12659/AJCR.935355

Am J Case Rep 2022; 23:e935355

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923